# TB-500 FAQ: Safety, Mechanism, Dosage, and Regulatory Questions Answered

> TB-500 frequently asked questions — what it is, what it does, whether it is safe, FDA approval and 503A status, the tumor-angiogenesis question, and the thymosin beta-4 fragment caveat. Direct, cited answers.

The common questions about TB-500 — definitional, mechanistic, safety, dosing, and regulatory — each answered directly and cited where the claim is quantitative.

## Definitional

Common questions about what TB-500 is, what its name means, and what it has been studied for.

## Mechanism and effects

How TB-500 works at the cellular level and what effects the literature reports.

## Safety

The honest safety picture — what is known, what is unknown, and the tumor-angiogenesis question.

## Regulatory and access

FDA approval, the 503A category, WADA status, and the racehorse association.

---

A cool-green research board for the TB-500 record — the Ac-LKKTETQ fragment routed as its own net apart from the full-length thymosin beta-4 it is sold as, the empty human-trial pad left open, the tumor-angiogenesis trace flagged and the FDA 503A standing read first; no clinic solders this board and nothing here is dispensed or sold.